ACLX Q4 2021 Earnings — Arcellx, Inc. Revenue & Financial Results | Market Cap Arena

ACLXArcellx, Inc.

$7B

Q4 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$331,000

Operating Income

-$21M

Net Income

-$21M

EPS (Diluted)

$-0.62

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$22M

Free Cash Flow

-$26M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$129M

Total Liabilities

$250M

Stockholders' Equity

-$122M

Cash & Equivalents

$31M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$331,000	-$165,000	-100.6%
Operating Income	-$21M	-$9M	-127.6%
Net Income	-$21M	-$9M	-127.3%